Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages.

scientific article published on 28 December 2015

Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.01876-15
P932PMC publication ID4775968
P698PubMed publication ID26711769

P50authorDavid P. FairlieQ40192238
Robert C. ReidQ43043214
Ronan KapetanovicQ56841623
Kaustav das GuptaQ86986044
Abishek IyerQ38328402
Matthew J. SweetQ40050893
P2093author name stringJuliana K Ariffin
P2860cites workMycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cellsQ40432586
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decayQ41042385
Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coliQ41213859
Mitochondrial control of apoptosisQ41339880
Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic modelQ41440235
Spiruchostatin A and B, novel histone deacetylase inhibitors, induce apoptosis through reactive oxygen species-mitochondria pathway in human lymphoma U937 cellsQ42704637
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infectionQ44166565
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophagesQ44503967
Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophagesQ46250361
Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function.Q52523838
Histone deacetylase inhibitors impair antibacterial defenses of macrophages.Q54352898
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitmentQ56879954
Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophagesQ59054084
Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritisQ61633704
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthmaQ83566208
Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulinQ84980015
Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsQ26853394
The complete genome sequence of Escherichia coli K-12Q27860542
Lysine acetylation targets protein complexes and co-regulates major cellular functionsQ27860589
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agentQ28191546
Histone acetylation and deacetylation: importance in inflammatory lung diseasesQ28237379
Of mice and not men: differences between mouse and human immunologyQ28246229
Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophagesQ28294510
Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cellsQ28540870
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerQ29615649
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsQ33243658
Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilumQ33471440
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.Q34180844
Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophagesQ34263905
Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine productionQ34428648
A key role for mitochondria in endothelial signaling by plasma cysteine/cystine redox potential.Q34673234
Histone deacetylase inhibitors and HIV latencyQ34816844
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with speciaQ35018415
Down-regulation of deacetylase HDAC6 inhibits the melanoma cell line A375.S2 growth through ROS-dependent mitochondrial pathwayQ35577980
Histone deacetylation in epigenetics: an attractive target for anticancer therapyQ36045533
Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogasterQ36259287
Conservation and divergence in the transcriptional programs of the human and mouse immune systemsQ36637283
Histone deacetylase inhibitors in inflammatory disease.Q37438530
Histone deacetylases as regulators of inflammation and immunityQ37875468
HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.Q37949185
HDAC inhibitors in HIV.Q37956178
Towards histone deacetylase inhibitors as new antimalarial drugs.Q38011212
Towards isozyme-selective HDAC inhibitors for interrogating disease.Q38029083
Differences in the repertoire, regulation and function of Toll-like Receptors and inflammasome-forming Nod-like Receptors between human and mouse.Q38094204
Murine models of infectious exacerbations of airway inflammationQ38097163
Histone deacetylase inhibitors and cell deathQ38217666
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersQ38240733
Depression of mitochondrial metabolism by downregulation of cytoplasmic deacetylase, HDAC6.Q39364627
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesQ39513114
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectreactive oxygen speciesQ424361
P304page(s)1521-1529
P577publication date2015-12-28
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleHistone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages
P478volume60

Reverse relations

cites work (P2860)
Q48939479An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice.
Q41382946Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
Q55266134Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages.
Q41991798Epigenetic regulation in bacterial infections: targeting histone deacetylases
Q41516139Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
Q49925707For when bacterial infections persist: Toll-like receptor-inducible direct antimicrobial pathways in macrophages.
Q94526741HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Q90705773HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis
Q47242802HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria Listeria monocytogenes.
Q98465730Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses to Mycobacterium tuberculosis
Q90482206Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis
Q40355358Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors.
Q57712790Targeting transcription factor lysine acetylation in inflammatory airway diseases
Q38926320The therapeutic potential of epigenetic manipulation during infectious diseases.
Q94461793Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

Search more.